Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yisu Li

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Neuroscience|December 15, 2021
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Neuroscience|December 15, 2021
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 3